Relevant bibliographies by topics / HEALTH EU / Journal articles

Journal articles on the topic 'HEALTH EU'

To see the other types of publications on this topic, follow the link: HEALTH EU.
Author: Grafiati
Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'HEALTH EU.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lewis, Sara. "EU health council meeting." Lancet 342, no. 8886-8887 (December 1993): 1546. http://dx.doi.org/10.1016/s0140-6736(05)80108-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

van de Pas, Remco, Samantha Battams, and Louise van Schaik. "The EU as a Global Health Actor: Policy Coherence, Health Diplomacy and WHO Reform." European Foreign Affairs Review 19, Issue 4 (December 1, 2014): 539–61. http://dx.doi.org/10.54648/eerr2014042.

Full text
Abstract:
This article explores the European Union's (EU) role and position on global health, including its role in the World Health Organization (WHO), and the impact of the Lisbon Treaty. Struggles over the implementation of the Lisbon Treaty potentially undermine the EU's ability to speak with one voice and its effectiveness. EU influence is determined by the remit of the EU (defined by competences outlined in the Treaty on the Functioning of the EU,TFEU), as well as the specific rules and procedures of international institutions. Based on empirical research, we considered the role of the EU in global health, via policy and policy coherence across the EU when it came to health matters (including the WHO reform) and through EU representation within multilateral fora. We conclude that the EU is a significant player in global health. It has established global health policy and played a leadership role in negotiating international health agreements. It has had a coordinated voice at the WHO, whilst being less cohesive in other multilateral health fora. Effectiveness of EU representation at the WHO was affected by a number of factors, including Member State's (MS) trust in EU representation and reluctance to cede competence on health matters, lack of EU flexibility in negotiations, lengthy EU coordination processes, MS vying for influence within the EU, and MS rather than EU engagement in behind the scenes and 'soft power' diplomacy. Vertical and horizontal integration within and across the EU also determined EU influence within international organizations. The Lisbon Treaty also had limited impact due to MS and others' concerns about the EU acting on institutional matters. The results are considered in light of the role that global health plays within foreign policy, the multitude of global health actors and prior theory and research on the EU's role in multilateral governance.
APA, Harvard, Vancouver, ISO, and other styles
3

Dove, Edward S. "EU Health Law & Policy: The Expansion of EU Power in Public Health and Health Care." SCRIPT-ed 17, no. 2 (August 6, 2020): 441–49. http://dx.doi.org/10.2966/scrip.170220.441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Richards, T. "EU reshuffle has health potential." BMJ 340, jan20 2 (January 20, 2010): c382. http://dx.doi.org/10.1136/bmj.c382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Muscat, N. A. "EU cross-border health care and public health." European Journal of Public Health 20, no. 2 (March 20, 2010): 128–29. http://dx.doi.org/10.1093/eurpub/ckq018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lilei, Song, and Bian Sai. "China-EU Two-level Cooperation and Challenges on Public Health during the COVID-19." Security science journal 2, no. 2 (December 13, 2021): 129–47. http://dx.doi.org/10.37458/ssj.2.2.9.

Full text
Abstract:
International public health cooperation has always been one of the typical issues of bilateral and multilateral diplomatic ties in the international community. As two important actors in the international community, China and the EU have worked on many transnational public health cooperation projects. The two-level division of the EU's foreign policy competence decided the Cooperation and Challenges on Public Health between China-EU. Cooperation with the EU member states is expanding, the cooperation with the level of the EU started to show up. Since the outbreak of COVID-19, both China and the EU have publicly expressed their support for WHO's anti-pandemic measures. China has actively provided public health aid to Central and Eastern European countries and shared the Anti-COVID-19 experience. In this article, the author reviewed the progress and mechanism of China-EU public health cooperation, discussed how China and the EU have jointly dealt with the pandemic by sharing experience, providing aids, strengthening multilateralism and international cooperation, and building a community with a healthy future for humankind since the outbreak of COVID-19. Facing the COVID-19，China-EU health cooperation should be further strengthened to show the importance of a community with a shared future for humanity.
APA, Harvard, Vancouver, ISO, and other styles
7

Wahner-Roedler, Dietlind L. "Trends in EU Health Care Systems." Mayo Clinic Proceedings 82, no. 2 (February 2007): 254. http://dx.doi.org/10.4065/82.2.254-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fahy, Nick. "Future EU strategy on health services." Clinical Medicine 7, no. 1 (January 1, 2007): 16–18. http://dx.doi.org/10.7861/clinmedicine.7-1-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wahner-Roedler, Dietlind L. "Trends in EU Health Care Systems." Mayo Clinic Proceedings 82, no. 2 (February 2007): 254. http://dx.doi.org/10.1016/s0025-6196(11)61015-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rogers, Arthur. "EU reprieve for health-related data." Lancet 345, no. 8965 (June 1995): 1626. http://dx.doi.org/10.1016/s0140-6736(95)90127-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Rogers, Arthur. "Obstacle to EU public health initiative." Lancet 345, no. 8948 (February 1995): 507. http://dx.doi.org/10.1016/s0140-6736(95)90592-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Shetty, Priya. "Members only for EU health care." Lancet Infectious Diseases 4, no. 5 (May 2004): 254. http://dx.doi.org/10.1016/s1473-3099(04)01013-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Senior, Kathryn. "Globalisation challenges the EU health strategy." Lancet Infectious Diseases 8, no. 2 (February 2008): 95. http://dx.doi.org/10.1016/s1473-3099(08)70012-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Batchelor, Paul. "Oral health and the EU referendum." British Dental Journal 219, no. 11 (December 2015): 513. http://dx.doi.org/10.1038/sj.bdj.2015.900.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Jönsson, Bengt. "Disruptive innovation and EU health policy." European Journal of Health Economics 18, no. 3 (October 26, 2016): 269–72. http://dx.doi.org/10.1007/s10198-016-0840-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Meek, C. "Immigration could strain EU health services." Canadian Medical Association Journal 171, no. 3 (August 3, 2004): 224. http://dx.doi.org/10.1503/cmaj.1041071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

 . "Conferentie ‘Health Care and EU law’." Tijdschrift voor Gezondheidsrecht 33, no. 4 (April 2009): 309. http://dx.doi.org/10.1007/bf03081621.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Androutsou, Lorena, and Theodoros Metaxas. "Health Systems that Meet the Health Needs of Refugees and Migrants." Journal of Developing Societies 35, no. 1 (March 2019): 83–104. http://dx.doi.org/10.1177/0169796x19826736.

Full text
Abstract:
This article discusses strategies designed to assist European Union (EU) health systems respond to the urgent health needs of refugees and migrants, assessing the situation from both an EU and global perspective. The article provides an overview of the legal framework, political policies, actions taken and the funding issues facing European institutions and international organizations as they seek to strengthen their response to healthcare needs of refugees and migrants. This article argues that EU member states need to be committed to improving the health status of refugees and migrants and reinforce their capabilities to advocate for respect for their basic right to health.
APA, Harvard, Vancouver, ISO, and other styles
19

Hervey, Tamara K., and Jean V. McHale. "Law, health and the European Union." Legal Studies 25, no. 2 (July 2005): 228–59. http://dx.doi.org/10.1111/j.1748-121x.2005.tb00614.x.

Full text
Abstract:
How does the European Union (EU) affect health law in its member states? Having defined ‘health law’, this article takes a multilevel governance perspective of the EU und its legal order, aid considers, through selected examples, the various modes of governance used by the EU applicable in the health law field. The article presents a spectrum of five different types of effect that the EU has on health law: strong effect from health-specific measures; strong effect from general measures; marginal effect; slow convergence effect; little prospect for effect.
APA, Harvard, Vancouver, ISO, and other styles
20

Exter, André den. "European Union Global Health Law." Право України, no. 2020/03 (2020): 17. http://dx.doi.org/10.33498/louu-2020-03-017.

Full text
Abstract:
The European Union is an important player in global health issues. This paper firstly explains the concept of EU global health law and then examines a number of areas where the EU acts and may influence, directly or indirectly, global health issues (eg, trade, public health, health migration, development aid, and health security). What follows is an attempt to tie up the threads more systematically by advocating a Global Health Convention, based on human rights principles. Such a shared vision on global health law may help the EU and Member States to respond more effectively to global health challenges such as international trade, public health security and health threats. In line with EU Council Conclusions 2010, the focus is on four dominant areas of EU law, explained in more detail. The variety of measures and activities embodies: external trade and global health; EU health law and external relations; health migration and development initiatives; global health security: the emerging health/security nexus. Author conclude that examining the EU’s role in the global health debate, has revealed a ‘hodgepodge’ of legal issues, rather than a distinct body of rules reflecting a coherent framework of EU law. As a result, its role in the global health is largely influenced by other policy areas than health. What is missing is a common global health policy. Communication 2010 provided key elements of what reflects a fragmented, highly compartmentalised approach. Balancing international trade and other economic interests with global health issues requires a shared vision and strategy what is global health. Here, it is argued that the EU should take the lead in drafting such a common policy based on previous experiences in close collaboration with the key global health actor: the WHO. Formulating and implementing a global health treaty at Member State level, a Framework Convention on Global Health could respond to trade, in a more systematic and coherent manner, reflecting international health law principles and specifying State obligations.
APA, Harvard, Vancouver, ISO, and other styles
21

Greer, Scott L. "Standing Up for Health? Health Departments in EU Health Policy Formulation." Social Policy & Administration 44, no. 2 (April 2010): 208–24. http://dx.doi.org/10.1111/j.1467-9515.2009.00709.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

DELHOMME, Vincent. "Emancipating Health from the Internal Market: For a Stronger EU (Legislative) Competence in Public Health." European Journal of Risk Regulation 11, no. 4 (November 17, 2020): 747–56. http://dx.doi.org/10.1017/err.2020.85.

Full text
Abstract:
It is a striking feature of European Union (EU) health law and policy that it has developed in a relative lack of awareness from the general public. This situation can be partly explained by the existence of only a limited competence in the field and the recourse to other legal bases to enact public health measures, particularly Article 114 TFEU. The use of internal market powers to conduct EU health policy has given rise to several problems, affecting the legitimacy of EU action and its capacity to adequately protect human health. Only a Treaty change can provide the EU with the clear competence and the solid legislative powers that it needs to tackle the various health challenges that Europe faces and will continue to face.
APA, Harvard, Vancouver, ISO, and other styles
23

Hussain, Tarique, Bi’e Tan, Gang Liu, Oso Abimbola Oladele, Najma Rahu, M. C. Tossou, and Yulong Yin. "Health-Promoting Properties ofEucommia ulmoides: A Review." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/5202908.

Full text
Abstract:
Eucommia ulmoides(EU) (also known as “Du Zhong” in Chinese language) is a plant containing various kinds of chemical constituents such as lignans, iridoids, phenolics, steroids, flavonoids, and other compounds. These constituents of EU possess various medicinal properties and have been used in Chinese Traditional Medicine (TCM) as a folk drink and functional food for several thousand years. EU has several pharmacological properties such as antioxidant, anti-inflammatory, antiallergic, antimicrobial, anticancer, antiaging, cardioprotective, and neuroprotective properties. Hence, it has been widely used solely or in combination with other compounds to treat cardiovascular and cerebrovascular diseases, sexual dysfunction, cancer, metabolic syndrome, and neurological diseases. This review paper summarizes the various active ingredients contained in EU and their health-promoting properties, thus serving as a reference material for the application of EU.
APA, Harvard, Vancouver, ISO, and other styles
24

Cristea, Mirela, Gratiela Georgiana Noja, Petru Stefea, and Adrian Lucian Sala. "The Impact of Population Aging and Public Health Support on EU Labor Markets." International Journal of Environmental Research and Public Health 17, no. 4 (February 24, 2020): 1439. http://dx.doi.org/10.3390/ijerph17041439.

Full text
Abstract:
Population aging and public health expenditure mainly dedicated to older dependent persons present major challenges for the European Union (EU) Member States, with profound implications for their economies and labor markets. Sustainable economic development relies on a well-balanced workforce of young and older people. As this balance shifts in favor of older people, productivity tends to suffer, on the one hand, and the older group demands more from health services, on the other hand. These requisites tend to manifest differently within developed and developing EU countries. This research aimed to assess population aging impacts on labor market coordinates (employment rate, labor productivity), in the framework of several health dimensions (namely, health government expenditure, hospital services, healthy life years, perceived health) and other economic and social factors. The analytical approach consisted of applying structural equation models, Gaussian graphical models, and macroeconometric models (robust regression and panel corrected standard errors) to EU panel data for the years 1995–2017. The results show significant dissimilarities between developed and developing EU countries, suggesting the need for specific policies and strategies for the labor market integration of older people, jointly with public health expenditure, with implications for EU labor market performance.
APA, Harvard, Vancouver, ISO, and other styles
25

Butschke, A., and A. Droß. "Die EU-Kosmetikverordnung." Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53, no. 6 (May 12, 2010): 606–9. http://dx.doi.org/10.1007/s00103-010-1059-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Khedkar, Sukhada, Stefano Ciliberti, and Stefanie Bröring. "The EU health claims regulation: implications for innovation in the EU food sector." British Food Journal 118, no. 11 (November 7, 2016): 2647–65. http://dx.doi.org/10.1108/bfj-01-2016-0021.

Full text
Abstract:
Purpose One of the objectives of the Nutrition and Health Claims Regulation (EC) No. 1924/2006 (NHCR) is protection and promotion of innovation in the food industry. The purpose of this paper is to explore the impact of the NHCR on both innovation and the sourcing of external knowledge in the European Union (EU) food sector. Design/methodology/approach An online survey was conducted which resulted in a sample of 105 EU companies for the study. Structural equation modelling was used to examine the nature of relationships that existed among the challenges related to the implementation of the NHCR, external sources of knowledge and innovation. Findings Challenges related to the NHCR are currently found to have a negative direct impact on product innovation. However, they have a positive indirect effect on product innovation, especially in the case of small and medium-sized enterprises. They also seem to positively affect external knowledge sourcing. Additionally, sources of external knowledge are found to have a positive effect on product and process innovations. Practical implications This study provides insights to different stakeholders in the food industry who might wish to work jointly and address the various issues related to the requirements of the NHCR and facilitate compliance with the regulation. Originality/value Understanding the impact of the NHCR on innovation seems pivotal because innovation plays an important role in the EU food sector. To this purpose, the paper delivers insights into some main compliance challenges and their effect on innovation.
APA, Harvard, Vancouver, ISO, and other styles
27

Feng, Yongqi, Xinye Yu, Yung-ho Chiu, and Tzu-Han Chang. "Dynamic Linkages among Economic Development, Energy Consumption, Environment and Health Sustainable in EU and Non-EU Countries." Healthcare 7, no. 4 (November 6, 2019): 138. http://dx.doi.org/10.3390/healthcare7040138.

Full text
Abstract:
There is a close and important relationship between environmental pollution and public health, and environmental pollution has an important impact on the public health. This study employed the two-stage meta-frontier dynamic network data envelopment analysis (TMDN-DEA) model to explore the environment pollution effects from energy consumption on the mortality of children and adult, tuberculosis rate, survival rate and health expenditure efficiencies in 28 EU countries and 53 non-EU countries from 2010 to 2014. We calculated the overall efficiency scores and the technology gap ratios of each EU and non-EU countries and the efficiencies of input and output variables in the production and health stage. The average overall efficiencies each year in EU countries are higher than in the non-EU countries. But EU countries have higher energy efficiency than non-EU countries, and non-EU countries have higher health efficiency than EU countries. The health expenditure efficiencies in the EU countries are obviously lower than those in non-EU countries. The renewable energy efficiencies are obviously higher than the non-renewable energy efficiencies; PM2.5 efficiencies are obviously higher than the CO2 efficiencies and the children’s mortality rate efficiencies are higher than the adult’s mortality rate efficiencies for EU countries and non-EU countries. The government management in the EU and non-EU countries should be strengthened to reduce the air pollutant and carbon dioxide emissions and raise energy transformation to the clean energy in renewable energy and improve health efficiencies in medical and health care field.
APA, Harvard, Vancouver, ISO, and other styles
28

Yokoyama, Hisayo, Daiki Imai, Yuta Suzuki, Akira Ogita, Hitoshi Watanabe, Haruka Kawabata, Takaaki Miyake, et al. "Health Literacy among Japanese College Students: Association with Healthy Lifestyle and Subjective Health Status." Healthcare 11, no. 5 (February 27, 2023): 704. http://dx.doi.org/10.3390/healthcare11050704.

Full text
Abstract:
The improvement of health literacy (HL) is a critical issue for college students who are in the transitional period to adulthood and are establishing their subsequent lifestyles. The present study aimed to evaluate the current state of HL among college students and to explore the factors that influence HL. Moreover, it investigated the relationship between HL and health conditions. For this study, the researchers conducted an online survey of college students. The questionnaire consisted of the Japanese version of the 47-item European Health Literacy Survey Questionnaire (HLS-EU-Q47), which is a self-assessment tool for HL that covers the major health issues of college students and health-related quality of life. The study analyzed 1049 valid responses. Based on the HLS-EU-Q47 total score, 85% of the participants exhibited problematic or unsatisfactory HL levels. Participants who reported high levels of healthy lifestyles obtained high HL scores. High levels of HL were associated with high levels of subjective health. Results from quantitative text analysis suggested that specific mindsets were correlated with high levels of competency in appraising health information among male students. In the future, educational intervention programs for college students need to be established to improve HL levels.
APA, Harvard, Vancouver, ISO, and other styles
29

Samarasekera, Udani. "New EU health programme comes into force." Lancet 397, no. 10281 (April 2021): 1252–53. http://dx.doi.org/10.1016/s0140-6736(21)00772-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Buchner, Benedikt. "Editorial Nutrition, Obesity and EU Health Policy." European Journal of Health Law 18, no. 1 (2011): 1–8. http://dx.doi.org/10.1163/157180911x546084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Roscam Abbing, Henriette D. C. "EU Cross-border Healthcare and Health Law." European Journal of Health Law 22, no. 1 (February 5, 2015): 1–12. http://dx.doi.org/10.1163/15718093-12341348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Potemkina, Olga. "EU on the way toward Health Union." Scientific and Analytical Herald of IE RAS, no. 18 (December 1, 2020): 32–38. http://dx.doi.org/10.15211/vestnikieran620203238.

Full text
Abstract:
The article deals with numerous initiatives of the EU Commission, both legislative and political, aimed at strengthening the MS coordination in the field of health. Based on the Commission’s recommendations on restrictions of freedom of movement, the author analyzes the «colour coding» of the EU regions to discover travelers arriving from «risk zones», and identifies conflicting approaches of Member States and other critics to this practice. The author shows interest in Commission’s activities for joint procurement of coronavirus vaccines and other medicines and medical instruments, which it carries out using the power received from the Member States. However, the author notes that only a few MS take advantage of these contracts, preferring their national procurement channels. The author considers Commission’s desire to take the next steps in the direction of the Health Union a significant event in the EU health policy. In conclusion, the author foresees upcoming discussions about who will make decisions in the field of health policy in the EU.
APA, Harvard, Vancouver, ISO, and other styles
33

Chamings, Richard. "EU membership and animal health and welfare." Veterinary Record 178, no. 19 (May 6, 2016): 479.1–479. http://dx.doi.org/10.1136/vr.i2522.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Woods, Joseph A. "EU membership and animal health and welfare." Veterinary Record 178, no. 19 (May 6, 2016): 479.2–480. http://dx.doi.org/10.1136/vr.i2523.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Wilson, Andrew. "EU membership and animal health and welfare." Veterinary Record 178, no. 20 (May 13, 2016): 509.1–509. http://dx.doi.org/10.1136/vr.i2674.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Richards, Tessa. "EU health budget may be almost halved." BMJ 332, no. 7536 (February 2, 2006): 257.3. http://dx.doi.org/10.1136/bmj.332.7536.257-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Watson, R. "Italian EU presidency brings ambitious health targets." BMJ 327, no. 7406 (July 10, 2003): 72—a—0. http://dx.doi.org/10.1136/bmj.327.7406.72-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Watson, Rory. "MEPs fight to reinstate EU health funding." BMJ 332, no. 7543 (March 23, 2006): 686.4. http://dx.doi.org/10.1136/bmj.332.7543.686-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Aris, Ben. "Slovenia's health system out-performs EU neighbours." Lancet 363, no. 9427 (June 2004): 2143–46. http://dx.doi.org/10.1016/s0140-6736(04)16537-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Watson, R. "EU says growth hormones pose health risk." BMJ 318, no. 7196 (May 29, 1999): 1442. http://dx.doi.org/10.1136/bmj.318.7196.1442a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Richards, T. "New EU health commissioner airs his priorities." BMJ 319, no. 7211 (September 11, 1999): 662. http://dx.doi.org/10.1136/bmj.319.7211.662.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Riemer-Hommel, P. "A2 EU health policy: cross-border controversies." European Journal of Oncology Nursing 14 (April 2010): S1. http://dx.doi.org/10.1016/s1462-3889(10)70013-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Koppelin, Frauke. "Deutsche Gesellschaft für Public Health: EU-Förderung." Public Health Forum 7, no. 2 (May 1, 1999): 21–22. http://dx.doi.org/10.1515/pubhef-1999-1612.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Chauzat, Marie-Pierre, and Magali Ribière-Chabert. "EU Reference Laboratory for Honey Bee Health." Bee World 90, no. 1 (January 2013): 10–11. http://dx.doi.org/10.1080/0005772x.2013.11417517.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Paju, Jaan. "Book review: EU Health Law and Policy." European Journal of Social Security 21, no. 4 (December 2019): 395–97. http://dx.doi.org/10.1177/1388262719890701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Richards, T. "Health issues rise up the EU agenda." BMJ 323, no. 7316 (October 6, 2001): 772. http://dx.doi.org/10.1136/bmj.323.7316.772b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Ferriman, A. "Blair backtracks on meeting EU health spending." BMJ 323, no. 7325 (December 8, 2001): 1325. http://dx.doi.org/10.1136/bmj.323.7325.1325a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Salomons, Erik M., and Michael Dittrich. "Health burden of road traffic noise in the EU in 2020–2035." Noise Control Engineering Journal 70, no. 5 (September 1, 2022): 446–55. http://dx.doi.org/10.3397/1/377038.

Full text
Abstract:
The negative health effects of road traffic noise in the EU are analyzed over the period 2020–2035. For a baseline scenario, with autonomous traffic growth and fleet development, we find that there will be 31 million highly annoyed persons and 15 million highly sleep-disturbed persons in the EU in 2030. The corresponding EU health burden in 2030 is equivalent to the loss of 1.7 million “healthy life years”. Various noise abatement scenarios are analyzed, with noise solutions such as quiet road surfaces, quiet tires, and electric vehicles. The health benefits of the scenarios are calculated as health-burden differences from the baseline scenario. The calculation methodology is based on the noise exposure distributions reported in 2017 by EU member states, for urban agglomerations and for major roads. Changes in noise exposure are calculated with EU model Cnossos for vehicle emission, considering different types of roads (residential streets, main roads, motorways,...), and taking into account the separate contributions of rolling noise and propulsion noise to the vehicle emission. Two different noise valuation methods are used to express the health benefits in Euros. The monetized health benefits are used as input for a cost-benefit analysis of the scenarios over the period 2020–2035. For quiet tires, for example, high health benefits and low costs are found, resulting in a high benefit-cost ratio. This work was part of a study for the European Commission, exploring different options for reducing the EU health burden caused by noise from road, rail, and air traffic.
APA, Harvard, Vancouver, ISO, and other styles
49

Rollet, Vincent. "Influence of EU-ASEAN health interregionalism on regional health governance." Asia Europe Journal 15, no. 3 (November 3, 2016): 243–59. http://dx.doi.org/10.1007/s10308-016-0463-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Salomons, Erik, and Michael Dittrich. "Health impact assessment of road traffic noise in the EU in 2020-2035." INTER-NOISE and NOISE-CON Congress and Conference Proceedings 263, no. 4 (August 1, 2021): 1977–88. http://dx.doi.org/10.3397/in-2021-2019.

Full text
Abstract:
The negative health effects of road traffic noise in the EU are analyzed over the period 20202035. For a baseline scenario, with autonomous traffic growth and fleet development, it is found that the EU health burden in 2030 is equivalent to the loss of 1.7 million 'healthy life years'. Various noise abatement scenarios are analyzed, with noise solutions such as quiet road surfaces, quiet tyres, and electric vehicles. The health benefits of the scenarios are calculated as healthburden differences from the baseline scenario. The calculation methodology is based on the noise exposure distributions reported in 2017 by EU member states, for urban agglomerations and for major roads. Changes in noise exposure are calculated with EU model Cnossos for vehicle emission, considering different types of roads (residential streets, main roads, motorways,...). The monetized health benefits are used as input for a costbenefit analysis of the scenarios over the period 2020-2035. For quiet tyres, for example, high health benefits and low costs are found, resulting in a high cost-to-benefit ratio. This work was part of a study for the European Commision, exploring different options for reducing the EU health burden caused by noise from road, rail, and air traffic.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'HEALTH EU' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography